India Steps Up Scrutiny After Chinese API Prices, Military Tensions Rise
Drug Shortages Not Expected In The Short-Term
A recent military skirmish with China and a 35-40% average increase in prices of drug raw materials has seen India step up scrutiny of imports from the country. While the industry is seeking a hike in domestic formulations prices, product shortages are not expected in the short term.
